Chinese medicine injection shuanghuanglian for treatment of acute upper respiratory tract infection : a systematic review of randomized controlled trials

Acute upper respiratory tract infections (AURTIs) are the illnesses caused by an acute infection with various viruses and bacteria involving the upper respiratory tract. Shuanghuanglian (SHL) injection, a Chinese medicine intravenous preparation extracted from honeysuckle, Scutellaria baicalensis, a...

Full description

Saved in:
Bibliographic Details
Published in:Evidence-based complementary and alternative medicine 2013-01, Vol.2013 (2013), p.1-7
Main Authors: Zhang, Hongwei, Chen, Qin, Zhou, Weiwei, Gao, Shi, Lin, Huiguang, Ye, Shuifen, Xu, Yihui, Cai, Jing
Format: Article
Language:English
Subjects:
Antibiotics
Bias
Chinese medicine
Clinical trials
Ear diseases
Evidence-based medicine
Fever
Herbal medicine
Infections
Injection
Intravenous administration
Otolaryngology
Quality
Respiratory tract
Respiratory tract diseases
Respiratory tract infection
Review
Systematic review
Tonsillitis
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acute upper respiratory tract infections (AURTIs) are the illnesses caused by an acute infection with various viruses and bacteria involving the upper respiratory tract. Shuanghuanglian (SHL) injection, a Chinese medicine intravenous preparation extracted from honeysuckle, Scutellaria baicalensis, and fructus forsythiae, is commonly used to treat AURTIs. Although it is used largely in Chinese hospitals, there is no substantial evidence to demonstrate its clinical effect on AURTIs. We conducted a systematic review to evaluate the effectiveness and safety of Shuanghuanglian injection for the treatment of acute upper respiratory tract infections.
ISSN:1741-427X
1741-4288
DOI:10.1155/2013/987326